A common but not well-known cause in anal fissure development and treatment failure: Isotretinoin treatment for acne vulgaris

dc.authorid0000-0002-9452-9276
dc.authorid0000-0002-0011-7570
dc.contributor.authorBasım, Pelin
dc.contributor.authorYüksel, Mavişe
dc.date.accessioned2021-06-16T07:51:19Z
dc.date.available2021-06-16T07:51:19Z
dc.date.issued2020
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Genel Cerrahi Ana Bilim Dalı
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Deri ve Zührevi Hastalıklar Ana Bilim Dalı
dc.description.abstractTo investigate the underrecognized effects of isotretinoin as a cause of anal fissures (AF) and compare AF patients undergoing systemic isotretinoin treatment (SIT) and those not receiving this treatment. This study was conducted with 118 patients with newly diagnosed AF, 54 undergoing SIT (Group 1) and 64 not undergoing SIT (Group 2). The same clinical treatment modalities including first-line conservative and medical treatments during the first eight weeks, followed by interventional methods (botulinum injection or sphincterotomy) for unresponsive/recurrent cases were used for all patients. A comparative analysis was also performed. Age and body mass index (BMI) were statistically low in group 1 (p=0.003; p=0.032). Similarly, the VAS pain and Wexner constipation scores and the duration of symptoms were lower in group 1 than Group 2 (p=0.003, p<0.001, and p<0.001, respectively). Atypical fissure localization was clearly associated with group 1 (p=0.012), and although SIT did not increase the surgery rate, atypical fissures and longer symptom duration constituted the most important factors determining requirement of surgical. SIT, a very successful treatment for nodulocystic acne disease, can facilitate AF development in younger individuals with a low BMI even without significant constipation.
dc.identifier.citationBasım, P. ve Yüksel, M. (2020). A common but not well-known cause in anal fissure development and treatment failure: Isotretinoin treatment for acne vulgaris. Medicine Science, 9(4), 970-977. https://dx.doi.org/10.5455/medscience.2020.07.141
dc.identifier.doi10.5455/medscience.2020.07.141
dc.identifier.endpage977
dc.identifier.issn2147-0634
dc.identifier.issue4
dc.identifier.startpage970
dc.identifier.urihttps://dx.doi.org/10.5455/medscience.2020.07.141
dc.identifier.urihttps://hdl.handle.net/20.500.12511/7194
dc.identifier.volume9
dc.indekslendigikaynakTR-Dizin
dc.language.isoen
dc.relation.ispartofMedicine Scienceen_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectAnal Fissure
dc.subjectIsotretinoin
dc.subjectAcne Vulgaris
dc.subjectRetinoids
dc.subjectSurgical Treatment
dc.titleA common but not well-known cause in anal fissure development and treatment failure: Isotretinoin treatment for acne vulgaris
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
Basim-Pelin-2020.pdf
Boyut:
335.96 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: